Exploring selected GEO datasets to identify the clinical implications of YAP in patients with HER2-positive GC, a significant correlation between YAP expression and poor prognosis exclusively within HER2-positive GC subtypes, compared to HER2-negatives was observed (Fig. 1M). This evidence concerns the gene YAP1 and gastric cancer.